Floatz logo

Therapeutic Asset Ratings

461 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Utomilumab
Non-Small Cell Lung Carcinoma
PfizerP3CCC (48)
Utomilumab
Neoplasm
PfizerP3CCC (48)
Voxelotor
Ulcer Of Lower Limbs
PfizerP3CCC (48)
Atirmociclib
Breast Neoplasm
PfizerP2CCC (48)
Letrozole
Small Cell Lung Carcinoma
PfizerP2CCC (48)
MIDAZOLAM
Breast Neoplasm
PfizerP2CCC (48)
PF-0704091
Small Cell Lung Carcinoma
PfizerP2CCC (48)
PF-07104091
Small Cell Lung Carcinoma
PfizerP2CCC (48)
pf-08653945
Obesity Disorder
PfizerP2CCC (48)
Atirmociclib
Healthy Adults
PfizerP1CC (47)
Itraconazole
Healthy Adults
PfizerP1CC (47)
pf-07257876
Head And Neck Squamous Cell Carcinoma
PfizerP1CC (47)
Probenecid
Healthy Adults
PfizerP1CC (47)
Ipilimumab
Liver And Intrahepatic Bile Duct Neoplasm
PfizerP1/2CC (47)
pf-08634404
Renal Cell Carcinoma
PfizerP1/2CC (47)
pf-08634404
Liver And Intrahepatic Bile Duct Neoplasm
PfizerP1/2CC (47)
pf-08634404
Kidney Neoplasm
PfizerP1/2CC (47)
Utomilumab
Ovarian Cancer
PfizerP3CC (46)
Atirmociclib
Prostate Cancer
PfizerP2CC (46)
PF-0704091
Breast Cancer
PfizerP2CC (46)
PF-0704091
Ovarian Cancer
PfizerP2CC (46)
PF-07104091
Ovarian Cancer
PfizerP2CC (46)
pf-06954522
Type 2 Diabetes Mellitus
PfizerP1CC (46)
FULVESTRANT
Colorectal Cancer
PfizerP1/2CC (45)
Inclacumab
Sickle Cell Disease
PfizerP3CC (44)
Showing 251 to 275 of 461 assets
PreviousPage 11 of 19Next